We are live on ! Find out more
ACP

Acuta Capital Partners Portfolio holdings

AUM $142M
1-Year Est. Return 783.79%
This Fund
S&P 500
This Quarter Est. Return
+25.88%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$266M
AUM Growth
+$58.2M
Cap. Flow
+$10.2M
Cap. Flow %
3.84%
Top 10 Hldgs %
51.18%
Holding
88
New
23
Increased
18
Reduced
16
Closed
21

Top Buys

Rank Stock Value
1
AERI
Aerie Pharmaceuticals
AERI
+$6.17M
2
CEMI
Chembio diagnostics, Inc.
CEMI
+$5.47M
3
EVDY
Everyday Health, Inc.
EVDY
+$4.74M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$4.54M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.97M

Top Sells

Rank Stock Value
1
RRM
RR MEDIA LTD ORD SHS (ISR)
RRM
+$8M
2
FOLD
Amicus Therapeutics
FOLD
+$3.32M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.2M
4
MDVN
MEDIVATION, INC.
MDVN
+$3.02M
5
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
+$2.96M

Sector Composition

Rank Sector Weight
1 Healthcare 68.34%
2 Technology 2.54%
3 Industrials 0.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IOVA icon
1
Iovance Biotherapeutics
IOVA
$1.93B
$26.6M 9.98%
3,229,916
-2,500
-0.1% -$21.1K
VCYT icon
2
Veracyte
VCYT
$3.58B
$23.9M 8.99%
3,144,649
-42,958
-1% -$243K
IRIX icon
3
IRIDEX
IRIX
$14.4M
$17.7M 6.64%
1,220,611
+208,740
+21% +$3.17M
IMMU
4
DELISTED
Immunomedics Inc
IMMU
$12.5M 4.7%
3,850,000
-350,000
-8% -$979K
EVDY
5
DELISTED
Everyday Health, Inc.
EVDY
$11.9M 4.48%
1,550,000
+605,000
+64% +$4.74M
AERI
6
DELISTED
Aerie Pharmaceuticals
AERI
$10.6M 3.97%
+280,000
New +$6.17M
XBI icon
7
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.62B
$9.94M 3.73%
+150,000
New +$9.28M
NDRM
8
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$8.56M 3.21%
462,956
-171,044
-27% -$2.96M
PDSB icon
9
PDS Biotechnology
PDSB
$40M
$7.32M 2.75%
35,150
+8,650
+33% +$1.71M
ASND icon
10
Ascendis Pharma A/S
ASND
$16B
$7.3M 2.74%
363,000
-109,800
-23% -$1.81M
ACAD icon
11
Acadia Pharmaceuticals
ACAD
$4.39B
$7M 2.63%
220,000
+134,001
+156% +$4.54M
MRVL icon
12
Marvell Technology
MRVL
$174B
$6.77M 2.54%
510,000
+270,412
+113% +$3.18M
CASM
13
DELISTED
CAS Medical Systems, Inc.
CASM
$6.65M 2.5%
3,845,365
+344,763
+10% +$598K
AKBA icon
14
Akebia Therapeutics
AKBA
$351M
$6.33M 2.38%
700,000
+100,000
+17% +$850K
CEMI
15
DELISTED
Chembio diagnostics, Inc.
CEMI
$5.71M 2.14%
771,676
+759,496
+6,236% +$5.47M
GWPH
16
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$5.51M 2.07%
+41,487
New +$3.97M
OXFD
17
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$5.12M 1.92%
407,815
-9,463
-2% -$95K
CEMP
18
DELISTED
Cempra, Inc.
CEMP
$5.08M 1.91%
210,000
– –
IWM icon
19
PUT
iShares Russell 2000 ETF
IWM
$81.5B
$4.97M 1.87%
40,000
-10,000
-20% -$1.22M
FOLD
20
DELISTED
Amicus Therapeutics
FOLD
$4.96M 1.86%
670,000
-491,545
-42% -$3.32M
WBMD
21
DELISTED
WebMD Health Corp.
WBMD
$4.72M 1.77%
95,000
+70,000
+280% +$3.86M
NBRV
22
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.11M 1.54%
2,334
+99
+4% +$191K
VNDA icon
23
Vanda Pharmaceuticals
VNDA
$315M
$4.09M 1.54%
+245,995
New +$3.31M
INNL
24
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.9M 1.47%
671,517
+103,380
+18% +$585K
DERM
25
DELISTED
Dermira, Inc.
DERM
$3.62M 1.36%
107,000
-63,000
-37% -$2.03M
1
2 3 4

Similar funds

EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
HA
HFG Advisors Cincinatti, Ohio $142M AUM 16.9% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCAM
Kagan Cocozza Asset Management Mickleton, New Jersey $142M AUM 12.02% 1-Year Est. Return

Acuta Capital Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Acuta Capital Partners held 88 positions worth $266M, up 28% from $208M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Acuta Capital Partners deployed $10.2M of net new capital in Q3 2016, opening 23 new positions and adding to 18 existing holdings. Its largest new stake was Aerie Pharmaceuticals: 280,000 shares worth $10.6M.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 73% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Amicus Therapeutics, an estimated $3.32M trimmed.

  • Acuta Capital Partners's largest Q3 2016 buy was Aerie Pharmaceuticals: 280,000 shares worth $10.6M.
  • Acuta Capital Partners added most to Chembio diagnostics, Inc. in Q3 2016, an estimated $5.47M increase.
  • Acuta Capital Partners's biggest Q3 2016 reduction was Amicus Therapeutics, cutting an estimated $3.32M.
  • Acuta Capital Partners fully exited RR MEDIA LTD ORD SHS (ISR) in Q3 2016, selling an estimated $8M.
  • Acuta Capital Partners's ten largest holdings make up 51% of its $266M portfolio in Q3 2016.
  • Acuta Capital Partners opened 23 new positions and closed 21 in Q3 2016.
  • Acuta Capital Partners's portfolio value rose 28% quarter-over-quarter to $266M.

Based on Acuta Capital Partners's 13F filing for Q3 2016, filed 14 Nov 2016.